Fibromyalgia is characterized by chronic pain and fatigue as well as heightened sensitivity to pressure. The affliction also causes stiffness, sleeping disorders, an inability to concentrate and anxiety or depression.
There is currently no cure for fibromyalgia and prescription medications can be costly and come with undesirable side effects.
Recently, researchers have found that women who suffer from fibromyalgia characteristically have lower levels of vitamin D in their blood stream. Dr. Florian Wepner at Orthopaedic Hospital Speising in Vienna, Austria, led a research team that conducted a randomized controlled trial of 30 women who suffered from fibromyalgia and had low vitamin D levels.
Half of these women were placed in a treatment group, in which their vitamin D intake was raised to normal levels for a period of 20 weeks. The other half of the women received no change in vitamin D levels.
The results, which were monitored throughout the trial process and then again 24 weeks after the trial had concluded, found that the women who received higher levels of vitamin D in their blood stream showed substantial improvements in physical functions, less morning fatigue and a significant reduction in pain levels. Wepner’s study was published in the February 2014 issue of Pain journal.
Vitamin D has also been found to benefit those suffering from multiple sclerosis, a central nervous system disease that negatively affects muscle control and strength, balance, vision and cognition.
Dr. Alberto Ascherio of Harvard School of Public Health in Boston led an international research team to study the effects of increased vitamin D on the progression of multiple sclerosis within early-stage patients.
The study, which has been published in the March 2014 issue of JAMA Neurology, found that of the 465 patients followed, those with adequate levels of vitamin D in their bloodstreams reported 57 per cent less new brain lesions, 57 per cent fewer relapses and 25 per cent lower increases in legion masses than their vitamin D deficient counterparts.
Symptoms of Parkinson’s disease, a degenerative central nervous system disorder, were also eased by an increase of vitamin D. Dr. Amie L Peterson's research team at the Veteran's Administration Medical Center in Portland, Oregon conducted a study on 286 Parkinson’s patients, 61 of which also suffered from dementia.
Results found that those with higher levels of vitamin D in their blood streams, including those with dementia, tested higher on areas of verbal fluency and verbal memory as well as reported lower levels of depression. The study was published in the September 2013 issue of the Journal of Parkinson’s Disease.
The work done by these researchers proves there are safer and more natural alternatives to prescription medications, and that in the case of fibromyalgia, multiple sclerosis and Parkinson’s disease natural treatment methods should be given more consideration.
To see the entire story go to: http://www.digitaljournal.com/pr/1946966
Studies show vitamin D helps manage chronic conditions
June 4, 2014 – According to a Digital Journal press release, recent studies suggest that vitamin D could be a safe, effective and inexpensive treatment for chronic conditions such as fibromyalgia, multiple sclerosis and Parkinson’s disease.
RMT Tech Talk: Copyright laws – how to avoid infringementWe often hear about clients receiving threatening correspondence from legal…
Joint mobilization plus exercise can effectively treat knee osteoarthritisAn intervention combining passive joint mobilization to realign the patellar…
Lifting weights for less than an hour a week can reduce risk of heart attackAMES, Iowa – Lifting weights for less than an hour…
Casey House spa aims to smash stigma that leaves people with HIV feeling untouchable with massageTORONTO—Randy Davis remembers attending a social function not long after he'd…
Healthy Living Expo
January 19, 2019
Our Health & Wellness Expo
January 27, 2019
Saskatoon Wellness Expo
February 1-3, 2019
Winnipeg Wellness Expo
February 15-17, 2019
Calgary Wellness Expo
March 8-9, 2019